These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28176241)

  • 21. Peri-operative therapy for operable gastroesophageal adenocarcinoma: past, present and future.
    Aggelis V; Cunningham D; Lordick F; Smyth EC
    Ann Oncol; 2018 Jun; 29(6):1377-1385. PubMed ID: 29771279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Esophagogastric junction and gastric adenocarcinoma: current challenges and future directions.
    Saba NF
    Oncology (Williston Park); 2014 Jun; 28(6):520-1. PubMed ID: 25134327
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus.
    Kleinberg L; Brock M; Gibson M
    Curr Treat Options Oncol; 2015 Jul; 16(7):35. PubMed ID: 26112428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?
    Lin D; Khan U; Goetze TO; Reizine N; Goodman KA; Shah MA; Catenacci DV; Al-Batran SE; Posey JA
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e88-e95. PubMed ID: 31099690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peri-operative chemotherapy in patients with oesophageal and gastro-oesophageal junction cancer - three years of experience.
    Pechačová Z; Zemanová M; Haruštiak T; Vítek P; Fencl P
    Prague Med Rep; 2013; 114(2):57-71. PubMed ID: 23777797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transition in biology and philosophy in the treatment of gastroesophageal junction adenocarcinoma.
    Tepper JE; O'Neil B
    J Clin Oncol; 2009 Feb; 27(6):836-7. PubMed ID: 19139425
    [No Abstract]   [Full Text] [Related]  

  • 27. The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona.
    Van Laethem JL; Carneiro F; Ducreux M; Messman H; Lordick F; Ilson DH; Allum WH; Haustermans K; Lepage C; Matysiak-Budnik T; Cats A; Schmiegel W; Cervantes A; Van Cutsem E; Rougier P; Seufferlein T
    Dig Liver Dis; 2016 Nov; 48(11):1283-1289. PubMed ID: 27590840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.
    Whiteman DC; Sadeghi S; Pandeya N; Smithers BM; Gotley DC; Bain CJ; Webb PM; Green AC;
    Gut; 2008 Feb; 57(2):173-80. PubMed ID: 17932103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I/II study of oxaliplatin and paclitaxel in patients with non-resectable cancer of the oesophagus and adenocarcinoma of the gastro-oesophageal junction: a study of the Arbeitsgemeinschaft Internistische Onkologie.
    Kaechele V; Moehler M; Lutz MP; von Wichert G; Eisele M; Klaus J; Galle PR; Adler G; Seufferlein T
    Cancer Chemother Pharmacol; 2010 May; 66(1):191-5. PubMed ID: 20354701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical approach and results of surgery in adenocarcinoma of the gastro-oesophageal junction.
    Ti TK
    Singapore Med J; 2000 Jan; 41(1):14-8. PubMed ID: 10783674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
    Lutz MP; Zalcberg JR; Ducreux M; Ajani JA; Allum W; Aust D; Bang YJ; Cascinu S; Hölscher A; Jankowski J; Jansen EP; Kisslich R; Lordick F; Mariette C; Moehler M; Oyama T; Roth A; Rueschoff J; Ruhstaller T; Seruca R; Stahl M; Sterzing F; van Cutsem E; van der Gaast A; van Lanschot J; Ychou M; Otto F;
    Eur J Cancer; 2012 Nov; 48(16):2941-53. PubMed ID: 22921186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic approaches to gastroesophageal junction adenocarcinomas.
    Blom RL; Bogush T; Brücher BL; Chang AC; Davydov M; Dudko E; Leong T; Polotsky B; Swanson PE; van Rossum PS; Ruurda JP; Sagaert X; Tjulandin S; Schraepen MC; Sosef MN; van Hillegersberg R
    Ann N Y Acad Sci; 2014 Sep; 1325():197-210. PubMed ID: 25266026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esophageal and esophagogastric junction cancers.
    Ajani JA; Barthel JS; Bentrem DJ; D'Amico TA; Das P; Denlinger CS; Fuchs CS; Gerdes H; Glasgow RE; Hayman JA; Hofstetter WL; Ilson DH; Keswani RN; Kleinberg LR; Korn WM; Lockhart AC; Mulcahy MF; Orringer MB; Osarogiagbon RU; Posey JA; Sasson AR; Scott WJ; Shibata S; Strong VE; Varghese TK; Warren G; Washington MK; Willett C; Wright CD;
    J Natl Compr Canc Netw; 2011 Aug; 9(8):830-87. PubMed ID: 21900218
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemoradiotherapy in tumours of the oesophagus and gastro-oesophageal junction.
    Hulshof MC; van Laarhoven HW
    Best Pract Res Clin Gastroenterol; 2016 Aug; 30(4):551-63. PubMed ID: 27644904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
    Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
    Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. It is time for a proper staging system for adenocarcinoma of the gastroesophageal junction.
    Pedrazzani C; de Manzoni G; Marrelli D; Roviello F
    J Clin Oncol; 2007 Mar; 25(7):907-8; author reply 908-9. PubMed ID: 17327616
    [No Abstract]   [Full Text] [Related]  

  • 38. Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches.
    Davidson M; Chau I
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):327-338. PubMed ID: 29431018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of gastroesophageal tumors.
    Gee DW; Rattner DW
    Oncologist; 2007 Feb; 12(2):175-85. PubMed ID: 17296813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant treatment of oesophageal adenocarcinoma.
    Robb WB; Naughton P; Walsh TN
    Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.